Terms: = Sarcomas AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb
53 results:
1. c-myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1.
Luo P; Fang J; Chen H; He F; Xiao S; Liu H; Zhu S; Luo J; Jiang C
Sci Rep; 2022 Apr; 12(1):6692. PubMed ID: 35461324
[TBL] [Abstract] [Full Text] [Related]
2. Transcription factor c-myb: novel prognostic factor in osteosarcoma.
Říhová K; Dúcka M; Zambo IS; Vymětalová L; Šrámek M; Trčka F; Verner J; Drápela S; Fedr R; Suchánková T; Pavlatovská B; Ondroušková E; Kubelková I; Zapletalová D; Tuček Š; Múdry P; Krákorová DA; Knopfová L; Šmarda J; Souček K; Borsig L; Beneš P
Clin Exp Metastasis; 2022 Apr; 39(2):375-390. PubMed ID: 34994868
[TBL] [Abstract] [Full Text] [Related]
3. Inhibiting the "Undruggable" RAS/Farnesyltransferase (FTase) Cancer Target by Manumycin-related Natural Products.
Silva LR; da Silva-Júnior EF
Curr Med Chem; 2022; 29(2):189-211. PubMed ID: 33719954
[TBL] [Abstract] [Full Text] [Related]
4. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
[TBL] [Abstract] [Full Text] [Related]
5. IGF2/IGF1R Signaling as a Therapeutic Target in myb-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors.
Andersson MK; Åman P; Stenman G
Cells; 2019 Aug; 8(8):. PubMed ID: 31426421
[TBL] [Abstract] [Full Text] [Related]
6. Outcome and Patterns of Relapse in Childhood Parameningeal Rhabdomyosarcoma Treated With Proton Beam Therapy.
Doyen J; Jazmati D; Geismar D; Frisch S; Schleithoff SS; Vermeren X; Scheer M; Blase C; Tippelt S; Timmermann B
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1043-1054. PubMed ID: 31419513
[TBL] [Abstract] [Full Text] [Related]
7. Transcriptional mechanisms that control expression of the macrophage colony-stimulating factor receptor locus.
Rojo R; Pridans C; Langlais D; Hume DA
Clin Sci (Lond); 2017 Aug; 131(16):2161-2182. PubMed ID: 28760770
[TBL] [Abstract] [Full Text] [Related]
8. mybL2 (B-myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.
Musa J; Aynaud MM; Mirabeau O; Delattre O; Grünewald TG
Cell Death Dis; 2017 Jun; 8(6):e2895. PubMed ID: 28640249
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb.
Guo X; Zhang J; Pang J; He S; Li G; Chong Y; Li C; Jiao Z; Zhang S; Shao M
Tumour Biol; 2016 Jul; 37(7):9181-7. PubMed ID: 26768615
[TBL] [Abstract] [Full Text] [Related]
10. The Expression of c-myb Correlates with the Levels of Rhabdomyosarcoma-specific Marker Myogenin.
Kaspar P; Zikova M; Bartunek P; Sterba J; Strnad H; Kren L; Sedlacek R
Sci Rep; 2015 Oct; 5():15090. PubMed ID: 26462877
[TBL] [Abstract] [Full Text] [Related]
11. KSHV miRNAs decrease expression of lytic genes in latently infected PEL and endothelial cells by targeting host transcription factors.
Plaisance-Bonstaff K; Choi HS; Beals T; Krueger BJ; Boss IW; Gay LA; Haecker I; Hu J; Renne R
Viruses; 2014 Oct; 6(10):4005-23. PubMed ID: 25341664
[TBL] [Abstract] [Full Text] [Related]
12. Survival after cancer in Italian persons with AIDS, 1986-2005: a population-based estimation.
Dal Maso L; Suligoi B; Franceschi S; Braga C; Buzzoni C; Polesel J; Zucchetto A; Piselli P; Falcini F; Caldarella A; Zanetti R; Vercelli M; Guzzinati S; Russo A; Tagliabue G; Iachetta F; Ferretti S; Limina RM; Mangone L; Michiara M; Stracci F; Pirino DR; Piffer S; Giacomin A; Vitarelli S; Mazzoleni G; Iannelli A; Contrino ML; Fusco M; Tumino R; Fanetti AC; De Paoli P; Decarli A; Serraino D;
J Acquir Immune Defic Syndr; 2014 Aug; 66(4):428-35. PubMed ID: 24798769
[TBL] [Abstract] [Full Text] [Related]
13. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract] [Full Text] [Related]
14. Overexpression of Cdk6 and Ccnd1 in chondrocytes inhibited chondrocyte maturation and caused p53-dependent apoptosis without enhancing proliferation.
Ito K; Maruyama Z; Sakai A; Izumi S; Moriishi T; Yoshida CA; Miyazaki T; Komori H; Takada K; Kawaguchi H; Komori T
Oncogene; 2014 Apr; 33(14):1862-71. PubMed ID: 23624920
[TBL] [Abstract] [Full Text] [Related]
15. Alteration of the microRNA expression profile in human osteosarcoma cells transfected with APE1 siRNA.
Dai N; Zhong ZY; Cun YP; Qing Y; Chen Ch; Jiang P; Li MX; Wang D
Neoplasma; 2013; 60(4):384-94. PubMed ID: 23581410
[TBL] [Abstract] [Full Text] [Related]
16. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract] [Full Text] [Related]
17. Array-based comparative genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumors.
Kanamori M; Sano A; Yasuda T; Hori T; Suzuki K
J Exp Clin Cancer Res; 2012 Nov; 31(1):100. PubMed ID: 23199169
[TBL] [Abstract] [Full Text] [Related]
18. Expression and function of FRA2/JUND in cutaneous T-cell lymphomas.
Nakayama T; Higuchi T; Oiso N; Kawada A; Yoshie O
Anticancer Res; 2012 Apr; 32(4):1367-73. PubMed ID: 22493372
[TBL] [Abstract] [Full Text] [Related]
19. Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor.
Iida M; Brand TM; Campbell DA; Li C; Wheeler DL
Oncogene; 2013 Feb; 32(6):759-67. PubMed ID: 22430206
[TBL] [Abstract] [Full Text] [Related]
20. Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia.
Wang HY; Huang LJ; Liu Z; Garcia R; Li S; Galliani CA
Hum Pathol; 2011 May; 42(5):749-58. PubMed ID: 21237494
[TBL] [Abstract] [Full Text] [Related]
[Next]